Drug-resistant tuberculosis: Pediatric guidelines

46Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting. Copyright © 2011 by Lippincott Williams & Wilkins.

Cite

CITATION STYLE

APA

Al-Dabbagh, M., Lapphra, K., McGloin, R., Inrig, K., Schaaf, H. S., Marais, B. J., … Kollmann, T. R. (2011). Drug-resistant tuberculosis: Pediatric guidelines. Pediatric Infectious Disease Journal, 30(6), 501–505. https://doi.org/10.1097/INF.0b013e31820b583d

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free